Shakirat Gold-Olufadi: Five Years of Building Apheresis Services in Lagos
Shakirat Gold-Olufadi, Resident Doctor at Brookdale University Hospital and Medical Center, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Therapeutic Apheresis and Dialysis, adding:
“You don’t know how much work you’ve done until you put it altogether and then do an analysis of all the data. Apheresis is that procedure where an apheresis machine separates whole blood into different components of blood.
The blood components can then be used for different purposes including therapeutic apheresis such as in plasma exchange especially when treating autoimmune conditions with autoantibodies like myasthenia gravis, red cell exchange most commonly done in sickle cell patients, and stem cell collection.
Apheresis is also important in getting seperate components of the blood like platelets where you are then able to give only the needed component of the blood such as what is done in plateletpharesis.
Dr Folasade Adelekan Popoola, the CEO of Next Hematology Medicare in Lagos has shown what is possible even in a resource limited setting. Happy to have been a part of this success story from the very beginning.
We are just getting started!
Here’s our paper on the 5 year journey since apheresis was established at Next Hematology in Lagos.”
Title: Establishing an Apheresis Medicine Program in a Resource-Constrained Setting: A 5-Year Experience From Lagos, Nigeria
Authors: Folasade Adelekan-Popoola, Shakirat Gold-Olufadi, Olufunto Olufela Kalejaiye, Abdullateef Ogala, Rasheed A. Balogun
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 16, 2026, 13:53Honey Blankenship: United by a Shared Commitment to the Bleeding Disorders Community
-
Aug 16, 2026, 13:46Sagar Bejalwar: A Rare Bleeding Disorder and the Importance of Specialized Care
-
Aug 16, 2026, 13:39Sharun Khan: Advancing Regenerative Medicine Through Veterinary Translational Science
-
Aug 16, 2026, 13:21Francois Roubille: New ESC Consensus on Inflammation in Coronary Syndromes
-
Aug 16, 2026, 13:05Neil Morgan: Submit Your Abstract for BSHT 2027
-
Aug 16, 2026, 12:50Heba Youssef: Can Cefoperazone Cause Coagulopathy?
-
Aug 16, 2026, 12:35Mohammad Alkhalil: Stroke Remains a Dreaded Complication in TAVI
-
Aug 16, 2026, 12:16Jeff Schaffnit: The Power of Community in Rare Blood Disorders
-
Aug 16, 2026, 12:03Fawaz AlOtaibi: Can AI Replace Contrast CTA for Vascular Screening?